Kayne Anderson Rudnick Investment Management
ACAD icon

Kayne Anderson Rudnick Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-55
Closed -$1K – 600
2022
Q1 		$1K Buy
+55
New +$1K ﹤0.01% 612
2021
Q1 		– Sell
-16
Closed -$1K – 558
2020
Q4 		$1K Buy
+16
New +$1K ﹤0.01% 562